5 Cheap Healthcare Stocks to Buy in 2023

4. Molecular Partners AG (NASDAQ:MOLN)

Latest P/E Ratio: 1.60

Molecular Partners AG (NASDAQ:MOLN) is a Swiss company headquartered in Schlieren, Switzerland. Its treatments target the coronavirus, tumors, cancers, and leukemias.

Three of the 943 hedge funds part of Insider Monkey’s database had bought Molecular Partners AG (NASDAQ:MOLN)’s shares during Q4 2022. Mark Lampert’s Biotechnology Value Fund / BVF Inc is the firm’s largest investor with a $2.8 million stake that comes via 443,221 shares.

Follow Molecular Partners Ag